Page 2 - Thorac Oncol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thorac oncol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thorac Oncol Today - Breaking & Trending Today

Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial

Segmentectomy should be considered as part of standard treatment for patients with
predominantly GGO NSCLC with a tumour size of 3 cm or less in diameter, including
GGO even if it exceeds 2 cm. ....

United States , J Thorac Cardiovasc , Gen Thorac Cardiovasc , Japan Clinical Oncology Group , Thorac Surg , Englj Med , Thorac Oncol , Thorac Cardiovasc Surg , Cancer Staging Project , American Thoracic , European Respiratory Society ,

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

Sotorasib significantly increased progression-free survival and had a more favourable
safety profile, compared with docetaxel, in patients with advanced NSCLC with the
KRASG12C mutation and who had been previously treated with other anticancer drugs. ....

Small Cell Lung Cancer Study Group , Clin Oncol , Treat Options Oncol , Small Cell Lung Cancer Study , Related Quality , Thorac Oncol , Lung Cancer , Cancer Res , Englj Med , Scare Cancer ,

Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study

These updated, long-term data from CROWN show the durable benefit of lorlatinib over
crizotinib in patients with treatment-naive, ALK-positive non-small-cell lung cancer
and support the use of first-line lorlatinib in patients with and without baseline
brain metastases. ....

Drug Administration , European Medicines Agency , Englj Med , Cancer Res , Med Chem , Clin Oncol , Thorac Oncol , Med Econ ,

European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

Cancer research is a crucial pillar for countries to deliver more affordable, higher
quality, and more equitable cancer care. Patients treated in research-active hospitals
have better outcomes than patients who are not treated in these settings. However,
cancer in Europe is at a crossroads. Cancer was already a leading cause of premature
death before the COVID-19 pandemic, and the disastrous effects of the pandemic on
early diagnosis and treatment will probably set back cancer outcomes in Europe by
almost a decade. ....

United Kingdom , United States , Le Chatelier , Champagne Ardenne , Nord Pas De Calais , Krasnoyarskiy Kray , Permskiy Kray , New York , White House , District Of Columbia , Good Friday , New South Wales , Le Chevalier , Provence Alpes Côd Azur , Noord Brabant , L Vivs Ka Oblast , World Bank , Russian Federation , Molina Barcel , Van Hemelrijck , Murphy Jr , Carnall Farrar , Gastroenterol Hepatol , International Standard Of Quality Cancer Care , International Cancer Research Partnership , Eurj Health Econ ,

Improved models of care for cancer survivors

Improved models of care for cancer survivors
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South Korea , United States , United Kingdom , Northern Ireland , City Of , Austj Gen , Asia Pacj Clin , Oncol Nurs Forum , World Health Organization , National Health Service England , National Health Service , National Research Council , Edinburgh Napier University , Royal College , Cancer Research United Kingdom , National Academies , Clinical Oncology Society Of Australia , National Academies Press , Health Organization , Soc Clin Oncol Educ Book , Glob Oncol , Scare Cancer , Pacj Clin Oncol , Natl Cancer Inst , Clin Oncol , Nurs Forum ,